The anti-inflammatory CD163+ macrophages (M2-like) were more prevalent in advanced tumor stage and exclusively located in invasive tumor front, whereas the CD80+ macrophages (M1-like) were predominant in less invasive tumors and predominantly distributed in tumor-adjacent normal mucosa (38). The gene discussed is CD163; the disease is neoplasm.